Format

Send to

Choose Destination
Eur J Pharmacol. 2014 Jan 15;723:202-6. doi: 10.1016/j.ejphar.2013.11.033. Epub 2013 Dec 4.

Effect of curcumin on diabetic peripheral neuropathic pain: possible involvement of opioid system.

Author information

1
Department of Pharmacology, School of Medicine, Kashan University of Medical Sciences, Kashan 87159-88141, Iran; Department of Addiction studies, School of Medicine, Kashan University of Medical Sciences, Kashan 87159-88141, Iran. Electronic address: banafshe57@hotmail.com.
2
Physiology Research Center, Kashan University of Medical Sciences, Kashan 87159-88141, Iran.
3
Research Center for Biochemistry and Nutrition in Metabolic Disorder, School of Medicine, Kashan University of Medical Sciences, Kashan 87159-88141, Iran.
4
Department of Pharmacology, School of Medicine, Kashan University of Medical Sciences, Kashan 87159-88141, Iran; Physiology Research Center, Kashan University of Medical Sciences, Kashan 87159-88141, Iran.
5
Department of Pharmacology, School of Medicine, Kashan University of Medical Sciences, Kashan 87159-88141, Iran.

Abstract

Neuropathic pain is one of the most common complications of diabetes mellitus. As efficacy and tolerability of current therapy for neuropathic pain are not ideal, we need to develop the novel drug for better treatment. Curcumin as a natural flavonoid from Curcuma longa has considerable effects on nervous system such as, antidepressant, antinociceptive and neuroprotective effects. The present study was designed to investigate the effect of curcumin on diabetic peripheral neuropathic pain and possible involvement of opioid system. A single dose of 60mg/kg streptozotocin was injected intraperitoneally to induce diabetes in rats. STZ-induced diabetic rats were treated with curcumin (50mg/kg/day) acute and chronically. Thermal hyperalgesia and mechanical allodynia were measured on the days 0, 7, 14 and 21 after diabetes induction as behavioral scores of neuropathic pain. Chronic, but not acute, treatment with curcumin prevents the weight loss and attenuates mechanical allodynia in STZ-induced diabetic rats. Pretreatment with naloxone (1mg/kg) significantly reduced anti-allodynic effect of chronic curcumin in von Frey filament test. Our results suggest that curcumin can be considered as a new therapeutic potential for the treatment of diabetic neuropathic pain and the activation of opioid system may be involved in the antinociceptive effect of curcumin.

KEYWORDS:

Curcumin; Curcumin (PubChem CID: 969516); Diabetic peripheral neuropathic pain; Dimethyl sulphoxide (PubChem CID: 679); Mechanical allodynia; Naloxone (PubChem CID: 5464092); Rat; Streptozotocin; Streptozotocin (PubChem CID: 29327)

PMID:
24315931
DOI:
10.1016/j.ejphar.2013.11.033
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center